Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction--a meta analysis of 7 prospective clinical studies.

Fu M, Zhou J, Sun A, Zhang S, Zhang C, Zou Y, Fu M, Ge J.

Int J Cardiol. 2012 Feb 23;155(1):33-8. doi: 10.1016/j.ijcard.2011.01.081. Epub 2011 Apr 11.

PMID:
21481482
2.

Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.

Philbin EF, Rocco TA Jr, Lindenmuth NW, Ulrich K, Jenkins PL.

Am J Med. 2000 Dec 1;109(8):605-13.

PMID:
11099679
3.

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).

van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD; SENIORS Investigators.

J Am Coll Cardiol. 2009 Jun 9;53(23):2150-8. doi: 10.1016/j.jacc.2009.02.046.

4.

Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.

Tsuchihashi-Makaya M, Furumoto T, Kinugawa S, Hamaguchi S, Goto K, Goto D, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H; JCARE-CARD Investigators.

Hypertens Res. 2010 Mar;33(3):197-202. doi: 10.1038/hr.2009.199. Epub 2009 Dec 4.

PMID:
19960016
5.
6.

Long term prognosis of chronic heart failure: reduced vs preserved left ventricular ejection fraction.

Miyagishima K, Hiramitsu S, Kimura H, Mori K, Ueda T, Kato S, Kato Y, Ishikawa S, Iwase M, Morimoto S, Hishida H, Ozaki Y.

Circ J. 2009 Jan;73(1):92-9. Epub 2008 Dec 1.

8.
9.

Meta-analysis of Renin-Angiotensin-aldosterone blockade for heart failure in presence of preserved left ventricular function.

Meune C, Wahbi K, Duboc D, Weber S.

J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):368-75. doi: 10.1177/1074248410391667. Epub 2010 Dec 30. Review.

PMID:
21193681
12.

Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.

Peltier M, Houpe D, Cohen-Solal A, Béguin M, Levy F, Tribouilloy C.

Int J Cardiol. 2007 Jun 12;118(3):363-9. Epub 2006 Oct 16.

PMID:
17049391
13.

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction.

Lee VC, Rhew DC, Dylan M, Badamgarav E, Braunstein GD, Weingarten SR.

Ann Intern Med. 2004 Nov 2;141(9):693-704. Erratum in: Ann Intern Med. 2005 Mar 1;42(5):391. Dosage error in article text.

PMID:
15520426
14.

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.

Maggioni AP, Anand I, Gottlieb SO, Latini R, Tognoni G, Cohn JN; Val-HeFT Investigators (Valsartan Heart Failure Trial).

J Am Coll Cardiol. 2002 Oct 16;40(8):1414-21.

15.

Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.

Mujib M, Patel K, Fonarow GC, Kitzman DW, Zhang Y, Aban IB, Ekundayo OJ, Love TE, Kilgore ML, Allman RM, Gheorghiade M, Ahmed A.

Am J Med. 2013 May;126(5):401-10. doi: 10.1016/j.amjmed.2013.01.004. Epub 2013 Mar 16.

16.

Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.

Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM.

Pacing Clin Electrophysiol. 2010 Jun 1;33(6):696-704. doi: 10.1111/j.1540-8159.2009.02669.x. Epub 2010 Jan 5.

PMID:
20059719
17.
18.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.

Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.

Am Heart J. 2007 Jun;153(6):1064-73.

PMID:
17540211
19.

Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.

Ghali JK, Giles T, Gonzales M, Horswell R, Kumar S, Lejuene A, Livaudais GF, Sarkar IC.

J La State Med Soc. 1997 Dec;149(12):474-84.

PMID:
9425858

Supplemental Content

Support Center